1-2 of 2
Rodolfo Lanocita, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Activity and Safety of the Combined Therapy with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib In Heavily Pretreated Patients with Relapsed/Refractory Lymphomas: Preliminary Results of a Phase II Trial

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Simonetta Viviani, MD, Liliana Devizzi, MD, Paola Matteucci, MD, Alfonso MarchianoĢ€, MD, Rodolfo Lanocita, MD, Stefania Zambelli, MD, Roberto Sorasio, MD, Massimo Di Nicola, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2010) 116 (21): 2861.
https://doi.org/10.1182/blood.V116.21.2861.2861
Published: 2010
Journal Articles

Preliminary Results of a Phase II Trial with the Multikinase Inhibitor Sorafenib in Heavily Pretreated Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL).

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Liliana Devizzi, MD, Paola Matteucci, MD, Alfonso MarchianoĢ€, MD, Rodolfo Lanocita, MD, Michele Magni, MD, Anna Dodero, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2009) 114 (22): 1658.
https://doi.org/10.1182/blood.V114.22.1658.1658
Published: 2009